Arcadia Biosciences Balance Sheet - Annual (NASDAQ:RKDA)

Add to My Stocks
$1.72 $0.02 (1.24%) RKDA stock closing price Oct 26, 2016 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Arcadia Biosciences, and helps in stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Arcadia Biosciences stock analysis. A company releases its balance sheet every quarter along with its quarterly results. Arcadia Biosciences revenue was $5.41M and Arcadia Biosciences operating cash flow was $-15.1M for 2015. The balance sheet shows total liabilities of $34.01M and shareholders equity of $40.22M. View latest and last 10 year balance sheet data to check Arcadia Biosciences financial performance..

show more
Get Balance sheet for another ticker
Fiscal year is Jan - Dec. 2015 2014 2013
Marketable Securities26.27M--
Raw Materials---
Work In Progress---
Finished Goods---
Notes Receivable---
Other Current Assets0.69M0.27M0.25M
Arcadia Biosciences Total Current Assets
Property Plant & Equipment5.24M5.38M5.27M
Accumulated Depreciation4.65M4.65M4.33M
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances19.74M0.5M1.43M
Other Non-Current Assets1.86M2.14M2.53M
Deferred Charges---
Deposits & Other Assets0.02M2.81M0.06M
Arcadia Biosciences Total Assets
Notes Payable-5.6M4.56M
Accounts Payable2.42M3.19M2.51M
Current Portion Long-Term Debt---
Current Portion Capital Leases---
Accrued Expenses---
Income Taxes Payable---
Other Current Liabilities1.02M2.46M2.46M
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income2.63M3.63M4.37M
Convertible Debt---
Long-Term Debt24.93M8.86M9.92M
Non-Current Capital Leases---
Other Long-Term Liabilities3M3M3M
Arcadia Biosciences Total Liabilities
Minority Interest---
Preferred Stock-82.88M-
Common Stock Net0.04M--
Capital Surplus172.22M29.2M78.33M
Retained Earnings-131.92M-113.97M-95.63M
Treasury Stock---
Other Liabilities-0.11M--
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.

Apart from balance sheet items, an investor would do well to keep track of the Arcadia Biosciences stock price by looking at Arcadia Biosciences historical stock prices. One can compare PE with industry average by looking at the Arcadia Biosciences PE ratio chart. The common balance sheet items are:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for RKDA stock as of year is $74.24M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Arcadia Biosciences's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for RKDA stock stand at $34.01M.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio